Tia L. Bush, Chief Technology & Quality Ofc at Centessa Pharmaceuticals plc (CNTA), sold 40,000 shares at $28.00 ($1.1M) on 2025-11-17, disclosed to the SEC on 2025-11-18.
Scheduled sale ($1.1M) by Chief Technology & Quality Ofc under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| CNTA | SELL | 2025-09-11 | $1.0M | — | Filing → |
| CNTA | SELL | 2025-02-04 | $185K | — | Filing → |
| CNTA | SELL | 2024-12-17 | $635K | — | Filing → |